Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Safe Supply Streaming Portfolio Company Safety Strips, Provides Corporate Update (click to learn more) Saturn Oil & Gas Inc. Announces $525 Million Accretive Core-Area Saskatchewan Asset Acquisition (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aptevo Therapeutics Inc APVO

Healthcare Biotechnology
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company. It is focused on developing novel immunotherapy candidates for the treatment of different forms of cancer. It has developed two versatile and enabling platform technologies for rational design of precision immune modulatory drugs. Its lead clinical candidates, APVO436 and ALG.APV-527, and preclinical candidates, APVO603 and... see more

Recent & Breaking News (NDAQ:APVO)

Aptevo Therapeutics Expands Bispecific Antibody Portfolio

GlobeNewswire March 14, 2017

Aptevo Therapeutics to Present at the 29th Annual ROTH Conference

GlobeNewswire March 6, 2017

12 Biggest Mid-Day Gainers For Friday

Benzinga.com  January 13, 2017

Aptevo Therapeutics Receives $20 Million Payment From Emergent BioSolutions

GlobeNewswire January 13, 2017

Aptevo Therapeutics Presents Data on Its ADAPTIR™ Antibody Platform at the 16th Annual PEPTALK Conference

GlobeNewswire January 12, 2017

Aptevo Therapeutics Resumes IXINITY Manufacturing; Anticipates Re-Entering the Market in the Second Quarter of 2017

GlobeNewswire January 4, 2017

Aptevo Therapeutics to Present at the 28th Annual Piper Jaffray Healthcare Conference

GlobeNewswire November 23, 2016

Aptevo Therapeutics Augments Leadership Team

GlobeNewswire September 15, 2016

Stocks Hitting 52-Week Lows

Benzinga.com  September 8, 2016